GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Perspective Therapeutics Inc (AMEX:CATX) » Definitions » Cyclically Adjusted PB Ratio

CATX (Perspective Therapeutics) Cyclically Adjusted PB Ratio : 0.81 (As of May. 30, 2025)


View and export this data going back to 2005. Start your Free Trial

What is Perspective Therapeutics Cyclically Adjusted PB Ratio?

As of today (2025-05-30), Perspective Therapeutics's current share price is $2.70. Perspective Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $3.33. Perspective Therapeutics's Cyclically Adjusted PB Ratio for today is 0.81.

The historical rank and industry rank for Perspective Therapeutics's Cyclically Adjusted PB Ratio or its related term are showing as below:

CATX' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.54   Med: 1.57   Max: 9.26
Current: 0.78

During the past years, Perspective Therapeutics's highest Cyclically Adjusted PB Ratio was 9.26. The lowest was 0.54. And the median was 1.57.

CATX's Cyclically Adjusted PB Ratio is ranked better than
76.01% of 496 companies
in the Medical Devices & Instruments industry
Industry Median: 1.82 vs CATX: 0.78

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Perspective Therapeutics's adjusted book value per share data for the three months ended in Mar. 2025 was $3.844. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.33 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Perspective Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Perspective Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perspective Therapeutics Cyclically Adjusted PB Ratio Chart

Perspective Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.24 3.05 1.01 1.20 0.96

Perspective Therapeutics Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.54 2.97 3.98 0.96 0.64

Competitive Comparison of Perspective Therapeutics's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Perspective Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Perspective Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Perspective Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Perspective Therapeutics's Cyclically Adjusted PB Ratio falls into.


;
;

Perspective Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Perspective Therapeutics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=2.70/3.33
=0.81

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perspective Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Perspective Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=3.844/134.9266*134.9266
=3.844

Current CPI (Mar. 2025) = 134.9266.

Perspective Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201506 3.782 100.684 5.068
201509 3.607 100.392 4.848
201512 3.372 99.792 4.559
201603 3.186 100.470 4.279
201606 2.981 101.688 3.955
201609 2.722 101.861 3.606
201612 2.466 101.863 3.266
201703 2.226 102.862 2.920
201706 1.927 103.349 2.516
201709 1.662 104.136 2.153
201712 1.428 104.011 1.852
201803 1.201 105.290 1.539
201806 0.893 106.317 1.133
201809 1.650 106.507 2.090
201812 1.435 105.998 1.827
201903 1.279 107.251 1.609
201906 1.140 108.070 1.423
201909 1.032 108.329 1.285
201912 0.911 108.420 1.134
202003 0.860 108.902 1.066
202006 0.831 108.767 1.031
202009 0.739 109.815 0.908
202012 1.464 109.897 1.797
202103 4.814 111.754 5.812
202106 4.750 114.631 5.591
202109 4.634 115.734 5.402
202112 4.533 117.630 5.200
202203 4.450 121.301 4.950
202206 4.314 125.017 4.656
202209 4.060 125.227 4.374
202212 3.845 125.222 4.143
202303 4.236 127.348 4.488
202306 3.874 128.729 4.061
202309 3.520 129.860 3.657
202312 2.668 129.419 2.782
202403 3.917 131.776 4.011
202406 5.057 132.554 5.148
202409 4.862 133.029 4.931
202412 4.113 133.157 4.168
202503 3.844 134.927 3.844

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Perspective Therapeutics  (AMEX:CATX) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Perspective Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Perspective Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Perspective Therapeutics Business Description

Traded in Other Exchanges
Address
2401 Elliott Avenue, Suite 320, Seattle, WA, USA, 98121
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Executives
Williamson Robert F Iii director 140 LASALLE AVENUE, PIEDMONT CA 94610
Lori A Woods officer: Vice President 350 HILLS STREET, SUITE 106, RICHLAND WA 99354
Johan M. Spoor director, officer: CEO 500 BOYLSTON STREET, SUITE 1600, BOSTON MA 02116
Heidi Henson director 2173 SALK AVENUE, SUITE 250, PMB#052, CARLSBAD CA 92008
Jonathan Robert Hunt officer: Chief Financial Officer 350 HILLS STREET, SUITE 106, RICHLAND WA 99354
Markus Puhlmann officer: Chief Medical Officer 350 HILLS STREET, SUITE 106, RICHLAND WA 99354
Frank Morich director 40 GUEST STREET, BOSTON MA 02135
Mark John Austin officer: Controller/Prin Fin&Acct Offic 350 HILLS ST, STE 106, RICHLAND WA 99354
Michael Krachon officer: VP of Sales & Marketing 350 HILLS STREET, SUITE 106, RICHLAND WA 99354
Michael W Mccormick director 9923 EAST BELL ROAD, STE 130, SCOTTSDALE AZ 85260
William Cavanagh officer: Vice President 350 HILLS STREET, SUITE 106, RICHLAND WA 99354
Philip J Vitale director 8849 E. CALLE DE LAS BRISAS, SCOTTSDALE AZ 85255
Alan Hoffmann director 3030 EAST CACTUS ROAD, SUITE 101, PHOENIX AZ 85032
Krista Cline officer: Dir. of Operations, Secretary 350 HILLS STREET, STE 106, RICHLAND WA 99354
Jennifer Streeter officer: VP of Human Resources 350 HILLS STREET SUITE 106, RICHLAND WA 99354